Bauer, Daniel, Buckley , Lorrene A. , Delafoy , Laure, Ellinger-Ziegelbauer , Heidrun, Fellows , Mick D. , Gerets , Helga H. J., Howe , Jonathan, Kaijser , Gerry , Nicolette , John, Pettersen , Betty A. and Schimpf , Brian (2021) A cross-industry survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10. Regulatory toxicology and pharmacology : RTP, 125. p. 105017. ISSN 1096-0295

Abstract

A cross-industry survey was conducted by EFPIA/IQ DruSafe in 2018 to provide information on photosafety evaluation of pharmaceuticals after implementation of ICH S10. This survey focused on the strategy utilized for photosafety risk assessment, the design of nonclinical (in vitro and in vivo) and clinical evaluations, the use of exposure margins in risk assessment, and regulatory interactions. The survey results indicated that a staged approach for phototoxicity assessment has been widely accepted by regulatory authorities globally. The OECD-based 3T3 NRU Phototoxicity Test is the most frequently used in vitro approach. Modifications to this assay suggested by ICH S10 are commonly applied. For in-vitro-positives, substantial margins from in vitro IC50 values under irradiation to Cmax (clinical) have enabled further development without the need for additional photosafety data. In vivo phototoxicity studies typically involve dosing rodents and exposing skin and eyes to simulated sunlight, and subsequently evaluating at least the skin for erythema and edema. However, no formal guidelines exist and protocols are less standardized across companies. A margin-of-safety approach (based on Cmax at NOAEL) has been successfully applied to support clinical development. Experience with dedicated clinical phototoxicity studies was limited, perhaps due to effective de-risking approaches employed based on ICH S10.

Item Type:	Article
Keywords:	photosafety, phototoxicity, survey, EFPIA, DruSafe, margins, ICH S10
Date Deposited:	28 Dec 2021 00:45
Last Modified:	28 Dec 2021 00:45
URI:	https://oak.novartis.com/id/eprint/44371